|
|||
|
Time: 5PM PT / 8PM ET
At the conclusion of this webinar, learners should be able to:
- Review the molecular and clinical classification of skeletal dysplasias
- Explore the benefits of enzymatic and genetic testing
- Learn the "red flag" signs and symptoms that suggest testing may be indicated
Klane White, MD, MSc
Director, Skeletal Health and Dysplasia Program
Professor, Orthopedics and Sports Medicine
Seattle Children's Hospital, University of Washington
Klane K. White, MD, MSc is a pediatric orthopaedic surgeon and Director of the Skeletal Health and Dysplasia Program at Seattle Children's Hospital, and Professor of Orthopaedic Surgery at the University of Washington.
Dr. White is an internationally recognized expert and advocate in the care of mucopolysaccharidosis and skeletal dysplasia. He serves on the Medical Advisory Board of Little People of America, the Scientific Advisory Board of the National MPS Society and is an executive founding member of the Skeletal Dysplasia Management Consortium.
In addition to skeletal dysplasia and the mucopolysaccharidoses, Dr. White's clinical and research interests also include the diagnosis and management of early onset scoliosis, metabolic bone disease, and complex spine deformity. Dr. White has authored more than 90 peer-reviewed publications, articles and book chapters, serves as reviewer for multiple medical journals, and is principal investigator in several multicenter research studies for rare disease
By completing and submitting this form, you are indicating that you would like to receive more information related to BioMarin’s products and services. BioMarin will not sell, rent, or otherwise distribute your information outside of BioMarin and related third parties. BioMarin will use the information you enter only in accordance with its Privacy Policy.
*It is your responsibility to ensure that your attendance at this event follows all applicable state and federal laws and ethics rules.
